Note 14 - Segments and Geographic Areas

3 Months Ended

Mar. 31, 2022

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14. Segments and Geographic Areas

The Company operates in one business segment—the research, development and sale of medical device robotics to improve minimally invasive surgery. The Company’s chief operating decision maker (determined to be the Chief Executive Officer), does not manage any part of the Company separately, and the allocation of resources and assessment of performance are based on the Company’s consolidated operating results.

The following table presents consolidated assets and long lived assets by geographic area, which includes property and equipment, intellectual property, and operating lease assets:

	March 31, 2022
	Long-Lived Assets			Total Assets
U.S.		30	%		78	%
EMEA
Switzerland		35	%		16	%
Italy		29	%		4	%
Other		6	%		1	%
Total EMEA		70	%		21	%
Asia		0	%		1	%
Total		100	%		100	%

	December 31, 2021
	Long-Lived Assets			Total Assets
U.S.		26	%		77	%
EMEA
Switzerland		34	%		16	%
Italy		36	%		5	%
Other		4	%		1	%
Total EMEA		74	%		22	%
Asia		0	%		1	%
Total		100	%		100	%

The Company recognizes sales by geographic area based on the country in which the customer is based. For the three months ended March 31, 2022 and 2021, 24% and 12%, respectively, of net revenue were generated in the United States; while 48% and 21%, respectively, were generated in Europe; and 28% and 67% were generated in Asia.